NCT00447954View on ClinicalTrials.gov

A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 5, 2007

Primary Completion Date

May 11, 2009

Study Completion Date

May 11, 2009

Conditions
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Interventions
COMBINATION_PRODUCT

High Dose NT-501 implant

High Dose NT-501

COMBINATION_PRODUCT

Low Dose NT-501 implant

Low Dose NT-501

OTHER

Sham

Sham Procedure

Trial Locations (8)

33101

Bascom Palmer Eye Institute, Miami

75231

Retina Foundation of Southwest, Dallas

77030

Vitreoretinal Consultants, Houston

84132

University of Utah, Salt Lake City

90211

Retina-Vitreous Associates Medical Group, Beverly Hills

33021-6746

Retina Group of Florida, Hollywood

02114

Ophthalmic Consultants of Boston, Boston

48073-6710

Beaumont Eye Institute, Royal Oak

Sponsors
All Listed Sponsors
lead

Neurotech Pharmaceuticals

INDUSTRY